About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Multicenter Hologic Tomosynthesis Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT00971087

Multicenter Hologic Tomosynthesis Study

The purpose of this image acquisition study is to compare, in a Reader Study, the performance of Tomosynthesis (3D) to (2D FFDM) conventional images in an enriched retrospective reader study. Syntheti...

Lead sponsor: Hologic, Inc.•22 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Hologic, Inc.

Age

18 - 110 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Female
•Any ethnic origin
•No contraindication of routine bilateral mammography

Exclusion Criteria

•Any contraindications to mammographic screening, including but not limited to:
•Significant existing breast trauma
•Pregnancy
•Lactating
•Previous surgical biopsy
•Previous breast cancer
•Placement of an internal breast marker
•Breast implants
•Unable to understand and execute written informed consent
•Breasts are too large to be imaged on the 24 cm by 29 cm detector with a single exposure

Related studies

RECRUITINGPhase 1

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

NCT06347068 · Breast Cancer, Relapse, and more

RECRUITINGPhase 3

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

NCT06500481 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more

A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship

NCT07655934 · Breast Cancer

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

NCT07436078 · Female Breast Cancer, Prostate Cancer, and more

RECRUITINGPhase 1/2

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

NCT06188520 · ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 26, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment3,521

Start dateSep 2009

Last updatedFeb 26, 2025

Condition

Locations shown

Scottsdale Medical Imaging Ltd. (SMIL)

Scottsdale, Arizona

Hoag Memorial Hospital

Newport Beach, California

UC Davis

Sacramento, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 26, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions